Aileron Therapeutics, Inc. (RNTX) SEC Filings — 2024

Filings

• Aileron Therapeutics Files 8-K on Financials — 8-K · Nov 14, 2024
• Aileron Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
• Aileron Therapeutics Files 8-K — 8-K · Aug 21, 2024
• Aileron Therapeutics Files 8-K on Financials — 8-K · Aug 14, 2024
• Aileron Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
• Aileron Therapeutics Files 8-K: Material Definitive Agreement — 8-K · Jul 26, 2024
• Aileron Therapeutics Sets August 20th Shareholder Meeting — DEF 14A · Jul 9, 2024
• Aileron Therapeutics Files 8-K on Shareholder Nominations — 8-K · Jun 5, 2024
• Aileron Therapeutics: CMO Departs, New Interim CMO Appointed — 8-K · May 16, 2024
• Aileron Therapeutics Files 8-K — 8-K · May 15, 2024
• Aileron Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
• Aileron Therapeutics Files 8-K — 8-K · May 1, 2024
• Aileron Therapeutics Files 10-K/A Amendment — 10-K/A · Apr 29, 2024
• Satter Amends Stake in Aileron Therapeutics — SC 13D/A · Apr 16, 2024
• Aileron Therapeutics Files 8-K — 8-K · Apr 15, 2024
• Aileron Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 15, 2024
• Aileron Therapeutics Reports Leadership and Compensation Changes — 8-K · Mar 29, 2024
• Aileron Therapeutics Files 8-K with Board and Compensation Updates — 8-K · Mar 15, 2024
• Aileron Therapeutics Inc SC 13G Filing — SC 13G · Mar 5, 2024
• Satter Amends Aileron Therapeutics 13D Filing — SC 13D/A · Mar 5, 2024
• Aileron Therapeutics Appoints New Chief Medical Officer — 8-K · Mar 1, 2024
• Aileron Therapeutics Files 8-K on Governance and Compensation Changes — 8-K · Feb 29, 2024
• Aileron Therapeutics Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Aileron Therapeutics Reports Officer/Director Changes — 8-K · Feb 13, 2024
• Aileron Therapeutics Director Kapnick Sells All Shares — SC 13G/A · Feb 5, 2024
• Aileron Therapeutics Files DEFA14A for 2023 Annual Meeting Proxy — DEFA14A · Jan 31, 2024
• Aileron Therapeutics Updates Corporate Address in 8-K Filing — 8-K · Jan 29, 2024
• Aileron Therapeutics Files Routine 8-K on Jan 25, 2024 — 8-K · Jan 25, 2024
• Aileron Therapeutics Amends 8-K, Updates Address & Confirms Nasdaq Listing — 8-K/A · Jan 11, 2024
• Aileron Therapeutics Faces Nasdaq Delisting, Changes Auditor — 8-K · Jan 10, 2024